Clinical trial Recruiting at 1 site Observational Ages 18 and up

Improving care for individuals with Lynch syndrome

Official title: Lynch Syndrome Integrative Epidemiology and Genetics (LINEAGE)

Run by University of Colorado, Denver · NCT06582914 · Data updated 2026-11-12

This study is trying to improve care for people with Lynch syndrome by collecting health information and samples to better understand the condition and support new ways to prevent and detect cancer.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations2 sites (Aurora, Colorado and 1 other locations)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedDecember 31, 2054
Study endsDecember 31, 2054
Registry record updatedJanuary 15, 2025
Trial IDNCT06582914 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with a confirmed pathogenic or likely pathogenic variant in specific Lynch syndrome-related genes.

Probably not a fit

Patients under 18 years old or those without a confirmed genetic variant associated with Lynch syndrome may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The LINEAGE Consortium aims to enhance the lives of individuals and families affected by Lynch syndrome through collaborative research. This observational study will establish a prospective cohort of patients with Lynch syndrome, collecting standardized clinical data and biosamples to investigate the epidemiology and genetic factors associated with the condition. The consortium will also support intervention trials focused on cancer prevention and early detection strategies for those at risk. By leveraging electronic health records and participant surveys, the study seeks to generate valuable insights into Lynch syndrome-related cancers.

Why it matters

Potential benefit: If successful, this study could lead to improved cancer prevention and early detection strategies for patients with Lynch syndrome.

How similar studies have gone: Other studies focusing on Lynch syndrome have shown promise in understanding cancer risks and improving patient outcomes, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Adults age over 18 years

  * Eligible patients must have at least one variant of uncertain significance (VUS), pathogenic or likely pathogenic variant (PV/LPV) in MLH1, MSH2, MSH6, PMS2, or EPCAM, which will be confirmed by genetic testing results (obtained as part of routine care) and a review of the variant in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/).
  * Individuals who are an obligate carrier of a LS PV/LPV that is confirmed in the family.

Exclusion Criteria:

* Age under 18

Where it's running

  • University of Colorado
    Aurora, Colorado, United States
    Recruiting
  • University of Chicago
    Chicago, Illinois, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.